HERTART ApS: Financial statements 2024
CVR: 32840787
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
HERTART ApS (CVR 32840787) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 4,190,854 and a net result of DKK 3,485,182 compared with DKK 1,596,417 the year before. That is an increase of 123.4% compared with the year before. Equity in the 2024 report amounted to DKK 8,674,184. The solvency ratio was 75.7%.
- Gross Profit
- DKK 4,190,854
- Profit/Loss
- DKK 3,485,182
- Equity
- DKK 8,674,184
- Total Assets
- DKK 11,463,633
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | 4.2 mio. | 3.5 mio. | 8.7 mio. | - |
| 2023 | - | 1.9 mio. | 1.6 mio. | 5.2 mio. | - |
| 2022 | - | 4.3 mio. | 3.4 mio. | 3.6 mio. | - |
| 2021 | - | 2.3 mio. | 1.8 mio. | 8 mio. | - |
| 2020 | - | 1 mio. | 1.1 mio. | 6.3 mio. | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
HERTART ApS has published its annual report for 2023. Gross profit came to DKK 1,875,975, and the net result was DKK 1,596,417.
About HERTART ApS
HERTART ApS is a Danish company of the type Anpartsselskab based in Greve, founded in 2010. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Per Svensson. The board consists of Per Svensson, Ralf Piegsa and Tom Faes. The company is owned by Vitrolife AB. The company has 0 employees (2012). In 2025, the company reported a gross profit of DKK 3,212,963 and a net result of DKK 2,675,487 compared with DKK 3,485,182 the year before. Equity in the 2025 report amounted to DKK 11,349,671.